New York Southern Bankruptcy Court

Case number: 7:19-bk-23648 - Purdue Pharma Inc. - New York Southern Bankruptcy Court

Case Information
Case title
Purdue Pharma Inc.
Chapter
11
Judge
Sean H. Lane
Filed
09/15/2019
Last Filing
07/03/2022
Asset
Yes
Vol
v
Docket Header

CLMAGT, JtAdm, MEGA




U.S. Bankruptcy Court
Southern District of New York (White Plains)
Bankruptcy Petition #: 19-23648-shl

Assigned to: Judge Sean H. Lane
Chapter 11
Voluntary
Asset


Date filed:  09/15/2019

Debtor

Purdue Pharma Inc.

One Stamford Forum
201 Tresser Boulevard
Stamford, CT 06901
FAIRFIELD-CT
Tax ID / EIN: 06-1307486

represented by
Marshall Scott Huebner

Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, NY 10017
(212) 450-4099
Fax : (212) 450-3099
Email: [email protected]

Eli J. Vonnegut

Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, NY 10017
212-450-4331
Email: [email protected]

U.S. Trustee

United States Trustee

Office of the United States Trustee - NY
Alexander Hamilton Custom House
One Bowling Green, Room 534
New York, NY 10004-1408
(212) 510-0500

 
 
Claims and Noticing Agent

Kroll Restructuring Administration LLC Claims Agent

(Formerly Prime Clerk LLC)
55 East 52nd Street
17th Floor
www.kroll.com
New York, NY 10055
(212) 257-5450
 
 

Latest Dockets
Date Filed#Docket Text
07/03/202212Docket Text
Certificate of Mailing Re: Notice of Case Reassignment (related document(s) (Related Doc # 11)) . Notice Date 07/03/2022. (Admin.) (Entered: 07/04/2022)
07/01/202211Docket Text
Notice of Case Reassignment From Judge Robert D. Drain to Judge Sean H. Lane. (Gomez, Jessica). (Entered: 07/01/2022)
11/06/2019Docket Text
Pending Deadlines for Schedules Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Schedules of Assets and Liabilities Terminated. (Vargas, Ana) (Entered: 11/06/2019)
11/06/20190Docket Text
Pending Deadlines for Schedules Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Schedules of Assets and Liabilities Terminated. (Vargas, Ana) (Entered: 11/06/2019)
11/01/201910Docket Text
Statement of Financial Affairs - Non-Individual /Statement of Financial Affairs for Purdue Pharma Inc. Filed by Eli J. Vonnegut on behalf of Purdue Pharma Inc.. (Vonnegut, Eli) (Entered: 11/01/2019)
11/01/20199Docket Text
Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Schedules of Assets and Liabilities for Purdue Pharma Inc. Filed by Eli J. Vonnegut on behalf of Purdue Pharma Inc.. (Vonnegut, Eli) (Entered: 11/01/2019)
09/19/20198Docket Text
Order signed on 9/18/2019 Granting Motion Extending the Time to File Schedules of Assets and Liabilities, Schedules of Current Income and Expenditures, Schedules of Executory Contracts and Unexpired Leases and Statements of Financial Affairs (Related Doc # 3) . (Vargas, Ana) (Entered: 09/19/2019)
09/19/2019Docket Text
Deficiencies Set: Schedule A/B due 9/30/2019. Schedule D due 9/30/2019. Schedule E/F due 9/30/2019. Schedule G due 9/30/2019. Schedule H due 9/30/2019. Summary of Assets and Liabilities due 9/30/2019. Statement of Financial Affairs due 9/30/2019. Incomplete Filings due by 9/30/2019. (Vargas, Ana) (Entered: 09/19/2019)
09/19/2019Docket Text
Claims and Noticing Agent, Prime Clerk LLC, added to the case. (Vargas, Ana) (Entered: 09/19/2019)
09/19/2019Docket Text
JOINTLY ADMINISTERED CHAPTER 11 CASES UNDER 19-23649-rdd Purdue Pharma L.P. (LEAD CASE): 19-23650-rdd Purdue Transdermal Technologies L.P.;19-23651-rdd Purdue Pharma Manufacturing L.P.;19-23652-rdd Purdue Pharmaceuticals L.P.;19-23653-rdd Imbrium Therapeutics L.P.;19-23654-rdd Adlon Therapeutics L.P.;19-23655-rdd Greenfield BioVentures L.P.;19-23656-rdd Seven Seas Hill Corp.;19-23657-rdd Ophir Green Corp.;19-23658-rdd Purdue Pharma of Puerto Rico;19-23659-rdd Avrio Health L.P.;19-23660-rdd Purdue Pharmaceutical Products L.P.;19-23661-rdd Purdue Neuroscience Company;19-23662-rdd Nayatt Cove Lifescience Inc.;19-23663-rdd Button Land L.P.;19-23664-rdd Paul Land Inc.;19-23665-rdd Quidnick Land L.P.;19-23666-rdd Rhodes Associates L.P.;19-23667-rdd Rhodes Pharmaceuticals L.P.;19-23668-rdd Rhodes Technologies;19-23669-rdd UDF LP;19-23670-rdd SVC Pharma LP and19-23671-rdd SVC Pharma Inc.. (Vargas, Ana) (Entered: 09/19/2019)